Skip to main content
Premium Trial:

Request an Annual Quote

Fisher HealthCare to Distribute Osmetech Products

NEW YORK (GenomeWeb News) – Osmetech today said that Thermo Fisher Scientific division Fisher HealthCare will distribute its eSensor XT-8 instrument platform and molecular diagnostic tests and consumables in the US.

The distribution agreement has a term of five years. Financial and other details were not disclosed.

"As we roll out our esensor XT-8 platform, Fisher Healthcare's considerable sales and marketing strength and established relationship with key customer accounts will play an important role in accelerating our market penetration," Osmetech CEO James White said in a statement.

Last July, Osmetech received US Food and Drug Administration 510(k) clearance for the eSensor platform and for its warfarin sensitivity test.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.